Deep sclerectomy and low dose mitomycin C: A randomised prospective trial in west Africa

British Journal of Ophthalmology

Volumn 90, Issue 3, 2006, Pages 310-313

  Mielke, C ^a   Dawda, V K ^b   Anand, N ^c,d  

^a Sankt Gertraude Kraukenhaus Hospital   (Germany)

^b Hospital of Coventry and Warwickshire   (United Kingdom)

^c CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; LOW DRUG DOSE; MALE; NIGERIA; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLERECTOMY; SURGICAL TECHNIQUE;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MITOMYCIN; NIGERIA; NUCLEIC ACID SYNTHESIS INHIBITORS; PROSPECTIVE STUDIES; SCLEROSTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644649092     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.079483     Document Type: Article

References (27)

1. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369-74.
2. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 1991;325:1412-7.
3. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology 2001;108:1751-6.
4. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St Lucia, West Indies. Part I. Prevalence findings. Ophthalmology 1989;96:1363-8.
5. Budenz DL, Singh K. Glaucoma care in West Africa. J Glaucoma 2001;10:348-53.
6. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
7. Egbert PR. Glaucoma in West Africa: a neglected problem. Br J Ophthalmol 2002;86:131-2.
8. Egbert PR, Williams AS, Singh K, et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 1993;116:612-6.
9. Singh K, Egbert PR, Byrd S, et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol 1997;123:48-53.
10. Anand N, Mielke C, Dawda VK. Trabulectomy outcomes in advanced glaucoma in Nigeria. Eye 2001;15:274-8.
11. Mielke C, Dawda VK, Anand N. Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria: a comparative study. Eye 2003;17:829-34.
12. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999;25:316-22.
13. Dahan E, Drusedau MU. Nonpenetrating filtration surgery for glaucoma: control by surgery only. J Cataract Refract Surg 2000;26:695-701.
14. Kozobolis VP, Christodoulakis EV, Tzanakis N, et al. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma 2002;11:287-93.
15. Cillino S, Di PF, Casuccio A, et al. Deep Sclerectomy versus Punch Trabeculectomy: Effect of Low-Dosage Mitomycin C. Ophthalmologica 2005;219:281-6.
16. Mermoud A, Schnyder CC. Nonpenetrating filtering surgery in glaucoma. Curr Opin Ophthalmol 2000;11:151-7.
17. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005;19:442-50.
18. Shaarawy T, Flammer J, Smits G, et al. Low first postoperative day intraocular pressure as a positive prognostic indicator in deep sclerectomy. Br J Ophthalmol 2004;88:658-61.
19. Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, et al. Nonpenetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol 2004;14:26-36.
20. Mermoud A, Karlen ME, Schnyder CC, et al. Nd:Yag goniopuncture after deep sclerectomy with collagen implant. Ophthalmic Surg Lasers 1999;30:120-5.
21. Thommy CP, Bhar IS. Trabeculectomy in Nigerian patients with open-angle glaucoma. Br J Ophthalmol 1979;63:636-42.
22. Sandford-Smith JH. The surgical treatment of open-angle glaucoma in Nigerians. Br J Ophthalmol 1978;62:283-6.
23. Chatterjee S, Ansari MW. Microsurgical trabeculectomy in Ghana. Br J Ophthalmol 1972;56:783-7.
24. Singh K, Byrd S, Egbert PR, et al. Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black west African population. J Glaucoma 1998;7:82-5.
25. Mermoud A, Salmon JF, Murray AD. Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol 1993;116:72-8.
26. Quigley HA, Buhrmann RR, West SK, et al. Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol 2000;84:860-4.
27. Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Br J Ophthalmol 2001;85:1028-30.